SKIN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that The Beauty Health Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of The Beauty Health Company (NASDAQ: SKIN) securities between May 10, 2022 and November 13, 2023, both dates inclusive (the “Class Period”), have until January 16, 2024 to seek appointment as lead plaintiff in the SKIN class action lawsuit.

Investors who suffered substantial losses are encouraged to contact the firm prior to the January 16, 2024 lead plaintiff motion deadline. If you wish to serve as lead plaintiff of the SKIN class action lawsuit, please provide your information by clicking here. You can also contact the firm’s lead plaintiff coordinator at [email protected] or 619-231-1058.

The lawsuit alleges that The Beauty Health Company made false and/or misleading statements and/or failed to disclose that: (1) The Beauty Health Company’s recently acquired skin care brands, including Goldfaden MD, Marin Bee, Naturopathica, Babor, and Oskia, were not performing as well as reported; (2) The Beauty Health Company’s organic sales growth was significantly overstated; and (3) as a result, The Beauty Health Company’s public statements were materially false and misleading at all relevant times.

If you purchased The Beauty Health Company securities during the Class Period and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact David A. Rosenfeld of Robbins Geller at 800/449-4900 or 619/231-1058, or via e-mail at [email protected] or visit our website.

How will this affect me?

As an investor in The Beauty Health Company securities during the Class Period, you may be eligible to participate in the class action lawsuit against the company. By seeking appointment as lead plaintiff, you have the opportunity to take a leading role in the legal proceedings and potentially recover some of your losses. It is important to act before the January 16, 2024 deadline to ensure your participation in the lawsuit.

How will this affect the world?

The outcome of the class action lawsuit against The Beauty Health Company could have broader implications for the skincare industry and for investors in other companies. If the allegations of false and misleading statements are proven true, it may lead to increased scrutiny of financial reporting practices in the beauty and wellness sector. This could potentially result in greater transparency and accountability among companies in the industry, ultimately benefiting investors and consumers alike.

Conclusion

The announcement of the class action lawsuit against The Beauty Health Company serves as a reminder of the importance of diligence and transparency in corporate practices. Investors who suffered losses during the Class Period have the opportunity to seek accountability and potential recovery through legal action. As the legal proceedings unfold, the implications of this case may extend beyond individual investors to impact the broader skincare industry and financial markets.